World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
32681
World Ranking
17374
National Ranking
96

Christian Marth publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christian Marth sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 586 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Christian Marth D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christian Marth sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Christian Marth is affiliated with Innsbruck Medical University in Austria and has contributed extensively to the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work spans several key subfields including Oncology, Reproductive Medicine, Obstetrics and Gynecology, Cancer Research, and Molecular Biology.

Their research topics are focused on areas such as ovarian cancer diagnosis and treatment, endometrial and cervical cancer treatments, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, cancer immunotherapy and biomarkers, uterine myomas and treatments, and endometriosis research and treatment.

Christian Marth has published numerous papers in prominent journals, including:

  • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma, 2020, International Journal of Gynecological Cancer
  • Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2022, Annals of Oncology
  • Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial, 2023, Annals of Oncology
  • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma, 2021, Radiotherapy and Oncology
  • ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease, 2024, Annals of Oncology

The scientist frequently collaborates with a core group of co-authors including Alain G. Zeimet, Philipp Harter, Nicoletta Colombo, Heidi Fiegl, and Katharina Leitner.

Christian Marth's most common publication venues demonstrate a consistent focus on clinical and oncological research, with significant contributions to:

  • Journal of Clinical Oncology
  • International Journal of Gynecological Cancer
  • Geburtshilfe und Frauenheilkunde
  • Annals of Oncology
  • Gynecologic Oncology

The research output by Christian Marth reflects a strong engagement in cancer-related medical research, notably in gynecologic oncology. The concentration on clinical guidelines, cancer treatment modalities, and molecular biology supports a broad scientific commitment to improving understanding and management of gynecologic cancers.

Best Publications

  • ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.

    Nicoletta Colombo;Carien Creutzberg;Frederic Amant;Tjalling Bosse

  • A pooled analysis of bone marrow micrometastasis in breast cancer

    Stephan Braun;Florian D. Vogl;Bjørn Naume;Wolfgang Janni

  • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

    Nicole Concin;Xavier Matias-Guiu;Ignace Vergote;David Cibula

  • Epigenetic stem cell signature in cancer.

    Martin Widschwendter;Heidi Fiegl;Heidi Fiegl;Daniel Egle;Elisabeth Mueller-Holzner

  • Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer

    Andrew E. Teschendorff;Usha Menon;Aleksandra Gentry-Maharaj;Susan J. Ramus

  • Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    N. Colombo;N. Colombo;S. Carinelli;A. Colombo;C. Marini

  • The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

    Dominik Wolf;Anna M. Wolf;Holger Rumpold;Heidi Fiegl

  • FBXW7/hCDC4 is a general tumor suppressor in human cancer

    Shahab Akhoondi;Dahui Sun;Natalie von der Lehr;Sophia Apostolidou

  • Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo- controlled trial

    Michael Gnant;Georg Pfeiler;Peter C Dubsky;Michael Hubalek

  • 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer Report From the Fourth Ovarian Cancer Consensus Conference

    Gavin C.E. Stuart;Henry Kitchener;Monica Bacon;Andreas duBois

  • A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

    Philipp Harter;Jalid Sehouli;Domenica Lorusso;Alexander Reuss

  • Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

    Michael Gnant;Brigitte Mlineritsch;Gero Luschin-Ebengreuth;Franz Kainberger

  • Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen

    Martin Widschwendter;Kimberly D. Siegmund;Peter A. Jones;Peter W. Laird

  • Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

    Andreas Du Bois;Anne Floquet;Jae Weon Kim;Jae Weon Kim;Joern Rau

  • Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

    Bradley J. Monk;Andrés Poveda;Ignace Vergote;Francesco Raspagliesi

  • Methylation and Silencing of the Retinoic Acid Receptor-β2 Gene in Breast Cancer

    Martin Widschwendter;Jennifer Berger;Martin Hermann;Hannes M. Müller

  • Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer

    W. Fraser Symmans;Christos Hatzis;Christos Sotiriou;Fabrice Andre

  • DNA Hypomethylation and Ovarian Cancer Biology

    Martin Widschwendter;Guanchao Jiang;Christian Woods;Hannes M. Müller

  • Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients

    Heidi Fiegl;Simone Millinger;Elisabeth Mueller-Holzner;Christian Marth

  • Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer

    Gilbert Spizzo;Philip Went;Stephan Dirnhofer;Peter Obrist

Frequent Co-Authors

Jalid Sehouli
Jalid Sehouli Charité - University Medicine Berlin
Richard Greil
Richard Greil Paracelsus Medical University
Nicoletta Colombo
Nicoletta Colombo University of Milano-Bicocca
Michael Gnant
Michael Gnant Medical University of Vienna
Sandro Pignata
Sandro Pignata National Cancer Institute
Raimund Jakesz
Raimund Jakesz Medical University of Vienna
Christian F. Singer
Christian F. Singer Medical University of Vienna
Robert L. Coleman
Robert L. Coleman The University of Texas MD Anderson Cancer Center
Domenica Lorusso
Domenica Lorusso Catholic University of the Sacred Heart

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in careers connected to medicine, there are several flexible and affordable online degree options to consider. A bachelors in health administration can lead to roles managing healthcare facilities, coordinating health services, or working in public health policy.

Those seeking further advancement may look into online mha programs affordable for graduate-level expertise in healthcare management. These programs can help open doors to higher-level leadership and administrative positions in hospitals or healthcare organizations.

If your interests lie in advanced clinical practice, the cheapest dnp online programs provide a pathway to become a Doctor of Nursing Practice. This degree is ideal for nurses aiming for leadership or specialized practice roles.

For students passionate about pharmaceuticals and patient care, you can also explore online pharmacy schools. Online pharmacy programs offer flexibility for working professionals and can be a stepping stone toward becoming a licensed pharmacist.

Best Scientists Citing Christian Marth

Trending Scientists

Recently Published Articles